Publications

Functional Mapping of Akt Signaling and Biomarkers of Response from the Fairlane Trial of Neoadjuvant Ipatasertib plus Paclitaxel for Triple-Negative Breast Cancer

AuthID
P-00W-7VR

Author(s)

Shi, Z

Wulfkuhle, J

Nowicka, M

Gallagher, RI

Saura, C

Nuciforo, PG

Calvo, I

Andersen, J

Passos Coelho, JL

Gil Gil, MJ

Bermejo, B

Pratt, DA

Ciruelos, EM

Villagrasa, P

Wongchenko, MJ

Petricoin, EF

Oliveira, M

Isakoff, SJ

Document Type

Article

Year published

2022

Published

in CLINICAL CANCER RESEARCH, ISSN: 1078-0432

Volume: 28, Issue: 5, Pages: 993-1003 (11)

Indexing

Wos^®

Scopus^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1158/1078-0432.ccr-21-2498

Pubmed: 34907082

Scopus: 2-s2.0-85125729523

Wos: WOS:000767267300001

Source Identifiers

ISSN: 1078-0432

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Functional Mapping of Akt Signaling and Biomarkers of Response from the Fairlane Trial of Neoadjuvant Ipatasertib plus Paclitaxel for Triple-Negative Breast Cancer

Useful Links

Get Help

Federated Authentication (Click on the image)

Functional Mapping of Akt Signaling and Biomarkers of Response from the Fairlane Trial of Neoadjuvant Ipatasertib plus Paclitaxel for Triple-Negative Breast Cancer

Useful Links

Get Help